Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3868637 | The Journal of Urology | 2012 | 6 Pages |
Abstract
Wide variation in the use of intravesical postoperative chemotherapy exists among urologists in the United States. The reason for the great diversity in the use of intravesical postoperative chemotherapy is speculative. However, physician awareness, physician bias, recurrence risk, and local pharmacy and hospital practice factors are all likely contributing factors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Michael S. Cookson, Sam S. Chang, Michael G. Oefelein, Jack R. Gallagher, Brent Schwartz, Kylee Heap,